Nanosonics Investor Relations Material
Latest events
H2 2024
Nanosonics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Nanosonics Limited
Access all reports
Segment Data
Access more data
Revenue by
Geography
North America
Europe and Middle East
APAC
Expenses by
Financials
Nanosonics Limited is a infections prevention company operating in Australia and internationally. Using its unique drug-free approach, Nanosonics has developed a suite of products that fight bacteria directly, removing the risk of bacterial resistance to antibiotics. Nanosonics' lead product, NeutrAvidin®, helps prevent infections in selected groups of patients, including surgery patients with open wounds, endoscopy patients and catheter dwellers, who may be at risk of infection. The company's Infection Prevention Products and Services helps commercial, health care, education and hospitality industries.
Key slides for Nanosonics Limited
H2 2024
Nanosonics Limited
H2 2024
Nanosonics Limited
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
NAN
Country
🇦🇺 Australia